ABCC1 and cancer: Deregulation of miR-326 was associated with several physiological and pathological processes; in cancer, miR-326 was associated with bone metastatic progression and chemotherapy resistance by modulating the expression of multidrug resistance-associated protein 1 MRP1 [47, 48].